Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.75 |
| ▸ | CNR1 | P21554 | 4/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | THPO | P40225 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | GMNN | O75496 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | APEX1 | P27695 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11165640 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11160652 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11156383 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11170587 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11167646 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11171046 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11160655 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11166255 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL15478743 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 | |
| SCHEMBL11156389 | 1.00 | CNR2 (0.75) | CNR2CNR1TSHRALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220370650-A1 | FORMULATIONS AND KITS FOR THE DIAGNOSTIC EVALUATION OF INFECTIOUS DISEASES AND METHODS THEREOF | VYRIPHARM ENTERPRISES, INC. | 2022-11-24 | — | — | US | claimed |
| US-20220305147-A1 | SYNTHETIC CANNABINOID COMBINATION THERAPY COMPOSITIONS AND METHODS FOR PERSONALIZED AND TARGETED THERAPIES INCLUDING THE TREATMENT OF INFECTIOUS DISEASES | VYRIPHARM ENTERPRISES, INC. | 2022-09-29 | — | — | US | claimed |
| US-11554184-B2 | Synthetic cannabinoid combination therapy compositions and methods for personalized and targeted therapies including the treatment of infectious diseases | VYRIPHARM ENTERPRISES, INC. (US) | 2023-01-17 | — | — | US | disclosed |
| US-20220370650-A1 | FORMULATIONS AND KITS FOR THE DIAGNOSTIC EVALUATION OF INFECTIOUS DISEASES AND METHODS THEREOF | VYRIPHARM ENTERPRISES, INC. | 2022-11-24 | — | — | US | disclosed |
| US-20220305147-A1 | SYNTHETIC CANNABINOID COMBINATION THERAPY COMPOSITIONS AND METHODS FOR PERSONALIZED AND TARGETED THERAPIES INCLUDING THE TREATMENT OF INFECTIOUS DISEASES | VYRIPHARM ENTERPRISES, INC. | 2022-09-29 | — | — | US | disclosed |
| WO-2020232350-A1 | ASSAYS FOR SYNTHETIC CANNABINOIDS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2020-11-19 | — | — | WO | disclosed |
| US-20180021247-A1 | TOPICAL COMPOSITIONS COMPRISING HYDROXY ACIDS AND CANNABINOIDS FOR SKIN CARE | Kannalnnovations LLC (US) | 2018-01-25 | — | — | US | disclosed |
| US-20180021247-A1 | TOPICAL COMPOSITIONS COMPRISING HYDROXY ACIDS AND CANNABINOIDS FOR SKIN CARE | Kannalnnovations LLC (US) | 2018-01-25 | — | — | US | disclosed |
| US-20170042791-A1 | TOPICAL COMPOSITIONS COMPRISING HYDROXY ACIDS AND CANNABINOIDS FOR SKIN CARE | KannaInnovations LLC (US) | 2017-02-16 | — | — | US | disclosed |
| US-20170042791-A1 | TOPICAL COMPOSITIONS COMPRISING HYDROXY ACIDS AND CANNABINOIDS FOR SKIN CARE | KannaInnovations LLC (US) | 2017-02-16 | — | — | US | disclosed |
| US-9347961-B2 | Test kit for the quantitative determination of narcotic drugs | CHIRON AS (NO) | 2016-05-24 | — | — | US | disclosed |
| EP-2722669-A1 | Method and device for detecting illegal drugs | Securetec Detektions-Systeme AG (DE) | 2014-04-23 | — | — | EP | disclosed |
| EP-2698385-A1 | Detection of synthetic cannabinoids | Randox Laboratories Ltd. (GB) | 2014-02-19 | — | — | EP | disclosed |
| EP-2687854-A1 | Test kit for the quantitative determination of narcotic drugs | Chiron AS (NO) | 2014-01-22 | — | — | EP | disclosed |
| US-8575230-B2 | Environment-friendly antifoulants for the prevention of biofouling | UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH (US) | 2013-11-05 | — | — | US | disclosed |
| US-20120208213-A1 | Detection of Synthetic Cannabinoids | RANDOX LABORATORIES LIMITED (GB) | 2012-08-16 | — | — | US | disclosed |
| US-20100256256-A1 | ENVIRONMENT-FRIENDLY ANTIFOULANTS FOR THE PREVENTION OF BIOFOULING | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2010-10-07 | — | — | US | disclosed |
| EP-0860168-B1 | Use of central cannbinoid receptor CB1 agonists | BAYER HEALTHCARE AG (DE) | 2007-08-08 | — | — | EP | disclosed |
| US-4391827-A | 3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor | PFIZER INC. (US) | 1983-07-05 | — | — | US | disclosed |
| US-4306097-A | 3-[2-Hydroxy-4-(substituted)phenyl]-cycloalkanol analgesic agents | PFIZER INC. (US) | 1981-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11554184-B2 | Synthetic cannabinoid combination therapy compositions and methods for personalized and targeted therapies including the treatment of infectious diseases | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TSHR 3314/4885 |
| US-20170042791-A1 | TOPICAL COMPOSITIONS COMPRISING HYDROXY ACIDS AND CANNABINOIDS FOR SKIN CARE | CNR2, CNR1, HCAR3 | CNR2 1/4885CNR1 2/4885TSHR 4646/4885 |
| US-20220370650-A1 | FORMULATIONS AND KITS FOR THE DIAGNOSTIC EVALUATION OF INFECTIOUS DISEASES AND METHODS THEREOF | ADA, SLC29A1, SLC29A2 | CNR2 4580/4885CNR1 4154/4885TSHR 3198/4885 |
| US-20100256256-A1 | ENVIRONMENT-FRIENDLY ANTIFOULANTS FOR THE PREVENTION OF BIOFOULING | TRPV1, CNR2, CNR1 | CNR2 2/4885CNR1 3/4885TSHR 3611/4885 |
| US-20120208213-A1 | Detection of Synthetic Cannabinoids | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TSHR 1782/4885 |
| US-20220305147-A1 | SYNTHETIC CANNABINOID COMBINATION THERAPY COMPOSITIONS AND METHODS FOR PERSONALIZED AND TARGETED THERAPIES INCLUDING THE TREATMENT OF INFECTIOUS DISEASES | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TSHR 3314/4885 |
| US-20180021247-A1 | TOPICAL COMPOSITIONS COMPRISING HYDROXY ACIDS AND CANNABINOIDS FOR SKIN CARE | CNR2, CNR1, HCAR3 | CNR2 1/4885CNR1 2/4885TSHR 4646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.